The aim of this work was to establish a porcine model for pancreatic cancer via conditional gene targeting. This technology (i.e. oncogene activation by Cre recombination) has been established in mice, but not in pigs. For the pig, conditional gene targeting was conducted, inserting mutated, oncogenic KRASG12D. To assess Cre activity and functionality in specific organs,
ROSA26 dual reporter pigs were generated and analysed. In addition, PDX-1-Cre targeted cells have been produced and nuclear transfer animals can be generated.
«
The aim of this work was to establish a porcine model for pancreatic cancer via conditional gene targeting. This technology (i.e. oncogene activation by Cre recombination) has been established in mice, but not in pigs. For the pig, conditional gene targeting was conducted, inserting mutated, oncogenic KRASG12D. To assess Cre activity and functionality in specific organs,
ROSA26 dual reporter pigs were generated and analysed. In addition, PDX-1-Cre targeted cells have been produced and nuclear tr...
»